Moramide intermediate (β-Methyl-α,α-diphenyl-4-morpholinebutanoic acid, on INCB Yellow List as 2-methyl-3-morpholino-1,1-diphenylpropane carboxylic acid) is a moramide precursor scheduled by UN Single Convention on Narcotic Drugs.

In the United States, moramide intermediate is designated as a Schedule II controlled substance,[2] and has an ACSCN of 9802.

The 2014 annual manufacturing quota was nil.

[3] In Australia, moramide intermediate is listed as a Schedule 9 (Prohibited Substance)[4]

This article about an organic compound is a stub.